Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1990-03-23
1991-11-05
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514410, A61K 3140
Patent
active
050632230
ABSTRACT:
Method of reducing the production of gonadal estrogenic steroidal hormones in animals by parenteral administration of defined quantities of cobalt protoporphyrin or cobalt mesoporphyrin.
REFERENCES:
patent: 4393071 (1983-07-01), Fujii et al.
patent: 4656186 (1987-04-01), Bommer et al.
patent: 4693885 (1987-04-01), Bommer et al.
Juzon Igakukui Zazshi, 67 384-9 (1961).
Chemical Abstracts, vol. 61, 1964, abstract 8762(df).
Belovetskaya, et al., Fiziol Biokhmontaq, 1983, (80-1), Chemical Abstracts, vol. 100, 1984, Abstract 45779k.
Feueq et al., Xenobiotica 15(5) 1985, pp. 407-412.
Gilbraith et al., Pharmacology 34, 1987, pp. 241-249.
Clinical Research 27(3) 578A, 1979.
Kitchen, Int. J. Biochem 15(4), 1981, pp. 479-485.
Mac Hadley, Endocrinology [Englewood Cliffs, N.J. Prentice-Hall, 1984], pp. 404 to 408 and 430.
Smith et al., Pharmacology 34, 1986, pp. 9-16.
Kikuchi et al., Molecular and Cellular Biochem 37(1), 1981, pp. 27-41.
Smith et al., Proc. Natl. Acad. Sci USA 79, 1982, pp. 7537 to 7541.
Drummond George S.
Kappas Attallah
Shah Mukund J.
The Rockefeller University
Ward E. C.
LandOfFree
Method of controlling androstene levels in vivo with cobalt porp does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of controlling androstene levels in vivo with cobalt porp, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of controlling androstene levels in vivo with cobalt porp will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-499439